AR090799A1 - USO INTRAUTERINO DE 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA - Google Patents

USO INTRAUTERINO DE 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA

Info

Publication number
AR090799A1
AR090799A1 ARP130101341A ARP130101341A AR090799A1 AR 090799 A1 AR090799 A1 AR 090799A1 AR P130101341 A ARP130101341 A AR P130101341A AR P130101341 A ARP130101341 A AR P130101341A AR 090799 A1 AR090799 A1 AR 090799A1
Authority
AR
Argentina
Prior art keywords
metilen
espirox
onas
intrauterine
methyl
Prior art date
Application number
ARP130101341A
Other languages
English (en)
Inventor
Dr Schmees Norbert
Dr Rse Lars
Valo Tuula
Dra Prelle Katja
Dr Nubbemeyer Reinhard
Korolainen Henriikka
Jukarainen Harri
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48142002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR090799(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of AR090799A1 publication Critical patent/AR090799A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Reivindicación 1: Aplicación intrauterina de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-3-onas de la fórmula general (1) en donde R⁶ y R⁷ son un átomo de hidrógeno o juntos son un grupo a-metileno. Reivindicación 5: Sistema intrauterino de acuerdo con la reivindicación 3, caracterizado porque del sistema se libera una dosis diaria de 1 - 200 mg de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-3-ona.
ARP130101341A 2012-04-23 2013-04-23 USO INTRAUTERINO DE 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA AR090799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102012206652 2012-04-23

Publications (1)

Publication Number Publication Date
AR090799A1 true AR090799A1 (es) 2014-12-10

Family

ID=48142002

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130101341A AR090799A1 (es) 2012-04-23 2013-04-23 USO INTRAUTERINO DE 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA

Country Status (28)

Country Link
US (1) US20150065472A1 (es)
EP (1) EP2841074A1 (es)
JP (1) JP2015514791A (es)
KR (1) KR20150004807A (es)
CN (1) CN104254333A (es)
AR (1) AR090799A1 (es)
AU (1) AU2013254840A1 (es)
BR (1) BR112014026193A2 (es)
CA (1) CA2871003A1 (es)
CL (1) CL2014002836A1 (es)
CO (1) CO7111255A2 (es)
CR (1) CR20140490A (es)
CU (1) CU20140121A7 (es)
DO (1) DOP2014000241A (es)
EA (1) EA201491922A1 (es)
EC (1) ECSP14024250A (es)
HK (1) HK1205000A1 (es)
IL (1) IL235095A0 (es)
IN (1) IN2014DN07839A (es)
MA (1) MA37444A1 (es)
MX (1) MX2014012849A (es)
PE (1) PE20142438A1 (es)
PH (1) PH12014502372A1 (es)
SG (1) SG11201406582XA (es)
TN (1) TN2014000444A1 (es)
TW (1) TW201350122A (es)
UY (1) UY34758A (es)
WO (1) WO2013160213A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015055789A1 (en) * 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
PL201878B1 (pl) * 2000-01-18 2009-05-29 Bayer Schering Pharma Ag Kompozycja farmaceutyczna w doustnej postaci dawkowania. zawierająca estrogen i drospirenon, zastosowanie kompozycji i preparat farmaceutyczny
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
DE102007063495A1 (de) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063496A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
PT2012063262W (pt) * 2010-11-08 2015-06-11 Hll Lifecare Ltd Um novo dispositivo intra-uterino com libertação controlada de cobre

Also Published As

Publication number Publication date
EP2841074A1 (de) 2015-03-04
BR112014026193A2 (pt) 2017-06-27
TN2014000444A1 (en) 2016-03-30
WO2013160213A1 (de) 2013-10-31
UY34758A (es) 2013-11-29
PE20142438A1 (es) 2015-02-01
US20150065472A1 (en) 2015-03-05
ECSP14024250A (es) 2015-12-31
HK1205000A1 (en) 2015-12-11
MX2014012849A (es) 2015-02-05
SG11201406582XA (en) 2014-11-27
CL2014002836A1 (es) 2015-03-13
TW201350122A (zh) 2013-12-16
CU20140121A7 (es) 2014-12-26
IL235095A0 (en) 2014-12-31
CN104254333A (zh) 2014-12-31
CO7111255A2 (es) 2014-11-10
MA37444A1 (fr) 2016-11-30
PH12014502372A1 (en) 2015-01-26
KR20150004807A (ko) 2015-01-13
CR20140490A (es) 2014-11-17
DOP2014000241A (es) 2014-12-31
IN2014DN07839A (es) 2015-04-24
EA201491922A1 (ru) 2015-04-30
CA2871003A1 (en) 2013-10-31
JP2015514791A (ja) 2015-05-21
AU2013254840A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
MX2021008976A (es) Inhibidores marcados de antigeno prostatico especifico de membrama (psma), su uso como agentes formadores de imagenes y agentes farmaceuticos para el tratamiento de cancer de prostata.
CL2016002312A1 (es) Modulador del receptor de andrógeno y usos de este.
CL2012003745A1 (es) Compuestos derivados de aminopirazoloquinazolinas, como inhibidores frente a la actividad fosforilante del receptor igf-1 localizado en membranas celulares; preparacion farmaceutica que los contiene; y su uso en el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
CR20140365A (es) Compuestos de carbamato y preparación y uso de los mismos
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
BR112014027981A2 (pt) compostos do tipo fumagilol e métodos de produção e utilização dos mesmos
MX2015008021A (es) Composiciones y metodos para administracion transdermica de hormonas y otros agentes medicos.
CL2016000148A1 (es) Nuevos compuestos isoindolina o isoquinolina, un proceso para su preparación y composiciones farmacéuticas que los contienen.
BR112015024877A2 (pt) vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose
AR090799A1 (es) USO INTRAUTERINO DE 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15b,16b-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASI COMO SU USO EN LA ANTICONCEPCION Y TERAPIA GINECOLOGICA
BR112015000647A2 (pt) composições orais líquidas e pediátricas que contêm nepadutant
GT201400225A (es) Uso de 18-metil-15b,16b-metilen-19-nor-20-espirox-4-en-3-onas en el tratamiento de menorragia, y sistemas intrauterinos que comprenden 18-metil-15b.16b-metilen-19-nor-20-espirox-4-en-3-onas para el tratamiento de trastornos con sangrado uterino
PH12015502029A1 (en) Phenylephrine resinate particles and use thereof in pharmaceutical formulations
PH12015502015A1 (en) Coated phenylephrine particles and use thereof in pharmaceutical formulations
CU24344B1 (es) Imidazo[1,2-a]piridincarboxamidas aminosustituidas
UY34430A (es) 18-metil-6,7-metilen-3-oxo-17-pregn-4-en-21,17bcarbolactona, preparados farmacéuticos que contienen los compuestos mencionados y su uso en la terapia de la endometriosis.
RU2011145777A (ru) Лекарственное средство, обладающее ранозаживляющей, противовоспалительной активностью
ITNA20130021U1 (it) "dispositivo medico - chirurgico che ha applicazione nel campo della odontoiatria, quale sistema di fissaggio di protesi dentaria mobile alla arcata dentaria".
UA65243U (ru) Применение радиоактивного цисплатина как вещества с усиленным противоопухолевым действием

Legal Events

Date Code Title Description
FB Suspension of granting procedure